Observational studyJournal of thrombosis and thrombolysis2019

Outcomes associated with under-dosing of rivaroxaban for management of non-valvular atrial fibrillation in real-world Japanese clinical settings.

Takanori Ikeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.